Samlyn Capital’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-798,873
| Closed | -$15.1M | – | 138 |
|
|
2019
Q3 | $15.1M | Sell |
798,873
-2,718,983
| -77% | -$51.3M | 0.37% | 57 |
|
|
2019
Q2 | $41.4M | Buy |
3,517,856
+331,873
| +10% | +$3.91M | 0.87% | 38 |
|
|
2019
Q1 | $43.5M | Buy |
3,185,983
+367,195
| +13% | +$5.01M | 1.03% | 34 |
|
|
2018
Q4 | $28.9M | Buy |
2,818,788
+904,098
| +47% | +$9.27M | 0.69% | 41 |
|
|
2018
Q3 | $31.9M | Buy |
1,914,690
+279,655
| +17% | +$4.66M | 0.72% | 55 |
|
|
2018
Q2 | $25.8M | Buy |
1,635,035
+1,071,998
| +190% | +$16.9M | 0.6% | 55 |
|
|
2018
Q1 | $7.15M | Buy |
+563,037
| New | +$7.15M | 0.16% | 85 |
|
|
2017
Q2 | – | Sell |
-181,143
| Closed | -$3.77M | – | 155 |
|
|
2017
Q1 | $3.77M | Buy |
181,143
+1,143
| +0.6% | +$23.8K | 0.09% | 114 |
|
|
2016
Q4 | $3.74M | Buy |
+180,000
| New | +$3.74M | 0.08% | 108 |
|